Shanghai Pharmaceuticals Holding Co.,Ltd.’s Net Profit Rose 11.4% in 2022

Shanghai Pharmaceuticals Holding Co.,Ltd. (上海医药集团股份有限公司) (601607.SH) reported a net profit of 7 billion yuan in 2022, up 11.4% year-on-year.

Meanwhile, the company posted 232 billion yuan in revenue, up 7.5% year-on-year.

At the end of the reporting period, it had 198.1 billion yuan in total assets and 120.1 billion yuan in total liabilities, with a liability-to-asset ratio of 60.6%.